Mizuho Securities USA’s West Pharmaceutical WST Stock Holding History

Mizuho Securities USA’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Buy	5,531 +1,182	+27%	+$361K	0.03%	438
2026 Q1	$1.09M	Sell	4,349 -889	-17%	-$221K	0.03%	526
2025 Q4	$1.45M	Buy	5,238 +1	+0%	+$274	0.02%	507
2025 Q3	$1.29M	Buy	5,237 +267	+5%	+$64.9K	0.03%	525
2025 Q2	$1.09M	Sell	4,970 -829	-14%	-$177K	0.02%	530
2025 Q1	$1.3M	Sell	5,799 -1,065	-16%	-$294K	0.03%	486
2024 Q4	$2.25M	Buy	6,864 +2,160	+46%	+$680K	0.04%	391
2024 Q3	$1.41M	Sell	4,704 -910	-16%	-$279K	0.03%	425
2024 Q2	$1.85M	Buy	+5,614	New	+$1.98M	0.04%	386

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mizuho Securities USA's WST Position: Q2 2026 in Review

Mizuho Securities USA increased its West Pharmaceutical (WST) stake by 27% in Q2 2026, buying an estimated $361K and bringing the position to 5,531 shares worth $1.99M. The position accounts for 0.03% of the portfolio, ranked #438.

Mizuho Securities USA first reported a position in WST in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.25M in Q4 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Mizuho Securities USA held 5,531 shares of West Pharmaceutical worth $1.99M as of Q2 2026.
Mizuho Securities USA bought 1,182 West Pharmaceutical shares in Q2 2026, an estimated $361K.
West Pharmaceutical made up 0.03% of Mizuho Securities USA's portfolio in Q2 2026, its #438 holding.
Mizuho Securities USA first reported a position in West Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
Mizuho Securities USA's West Pharmaceutical position peaked at $2.25M in Q4 2024.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.